Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study

Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study

Keith L Davis,1 Wenhui Wei,2 Juliana L Meyers,1 Brett S Kilpatrick,3 Naushira Pandya4 1RTI Health Solutions, Research Triangle Park, NC, USA; 2Sanofi US, Inc, Bridgewater, NJ, USA; 3AnalytiCare, LLC, Glenview, IL, USA; 4Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale,...

Full description

Bibliographic Details
Main Authors:	Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-10-01
Series:	Clinical Interventions in Aging
Subjects:	long-term care nursing homes type 2 diabetes mellitus insulin detemir insulin glargine NPH insulin
Online Access:	https://www.dovepress.com/use-of-basal-insulin-and-the-associated-clinical-outcomes-among-elderl-peer-reviewed-article-CIA

Similar Items

Clinical Experience of Insulin Detemir in Turkey: Efficacy and Safety Data From the PREDICTIVE™ Study
by: Gaye Akoz, et al.
Published: (2008-12-01)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
by: Dippel, Franz-Werner, et al.
Published: (2010-01-01)

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017-04-01)

Basal insulin analogues in the diabetes mellitus type 2 control — economic aspects
by: D. Yu. Belousov, et al.
Published: (2018-06-01)

Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats
by: Yusaku Mori, et al.
Published: (2018-05-01)

Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
by: I. N. Dyakov, et al.
Published: (2020-05-01)

Assessment of efficiency of application of various analogues of insulin in treatment of diabetes type 2
by: Rodionova T.l., et al.
Published: (2014-09-01)

Insulin glargine affects the expression of Igf-1r, Insr, and Igf-1 genes in colon and liver of diabetic rats
by: Clara I Juárez-Vázquez, et al.
Published: (2018-05-01)

Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients
by: Jakobsen Marie, et al.
Published: (2012-09-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A 1 chieve study
by: Subhash Kumar Wangnoo, et al.
Published: (2014-01-01)

Effect of insulin glargine on glycemic control in adolescents with type 1-diabetes
by: Hassan M. Mona, et al.
Published: (2015-06-01)

Custo-utilidade da insulina glargina e insulina isófana (NPH) para o tratamento de pacientes com diabetes mellitus tipo 2 atendidos no Sistema Único de Saúde do Município de Recife
by: CARVALHO, Dayse Cabral de
Published: (2017)

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan
by: Md Faruque Pathan, et al.
Published: (2012-01-01)

Successful Treatment with Bedtime Basal Insulin Added to Metformin without Weight Gain or Hypoglycaemia over Three Years
by: Bernardo Mertes, et al.
Published: (2020-04-01)

Análogos de insulina Insulin analogues
by: Manuel E. Licea Puig
Published: (2006-12-01)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
by: Lau IT, et al.
Published: (2017-06-01)

CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015-03-01)

Modern basal insulin analogs: An incomplete story
by: Awadhesh Kumar Singh, et al.
Published: (2014-01-01)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)

Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review
by: Dippel Franz-Werner, et al.
Published: (2011-10-01)

Cost-effectiveness of intermediate or long-acting insulin versus Exenatide in type 2 diabetes mellitus patients not optimally controlled on dual oral diabetes medications
by: Edwards KL, et al.
Published: (2006-09-01)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
by: Trevor J. Orchard, et al.
Published: (2017-06-01)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
by: Shafie AA, et al.
Published: (2020-06-01)

United States experience of insulin Degludec alone or in combination for type 1 and type 2 diabetes
by: Rendell M
Published: (2017-04-01)

The Role of Insulin Glargine and Human Insulin in the Regulation of Thyroid Proliferation Through Mitogenic Signaling
by: Xiaoli Sheng, et al.
Published: (2019-08-01)

Insulin choice in feline diabetes mellitus
by: Yaiza Gomez Mejias
Published: (2021-08-01)

Effects of combined treatment with rosiglitazone and NPH insulin on carbohydrate metabolism in patients with type 2 diabetes mellitus
by: O A Kandalintseva, et al.
Published: (2008-12-01)

Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world
by: Zhang T, et al.
Published: (2018-07-01)

Basal Insulin Initiation in Elderly Patients with Type 2 Diabetes in Taiwan: A Comparison with Younger Patients
by: Ming-Nan Chien, et al.
Published: (2015-09-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
by: Yu Mi Kang, et al.
Published: (2019-08-01)

On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01)

Intensive Insulin Titration with Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study
by: Ercan Tuncel, et al.
Published: (2015-09-01)

Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection technique
by: Sanjay Kalra, et al.
Published: (2012-01-01)

Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations
by: L. N. Shitov, et al.
Published: (2019-04-01)

Predictors of Glycemic Response and Change in HbA1c Following Newly Initiated Basal Insulin Among Insulin Naïve Adults With Type 2 Diabetes
by: Mojtaba Malek, et al.
Published: (2017-10-01)

Untersuchungen zur Wirtschaftlichkeit langwirksamer Insuline bei Patienten mit insulinbehandeltem Typ-2-Diabetes mellitus in Deutschland
by: Dippel, Franz-Werner
Published: (2013)

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019-11-01)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
by: Ivona Renata Yarek-Martynova, et al.
Published: (2011-12-01)

Cannot write session to /tmp/vufind_sessions/sess_aj4h5splfothg656o50vd4mair